Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SSH3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NFASC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SERTAD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCLK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAPGEF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRABD2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC375196 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PHF21A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLCH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HECTD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KMT2D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD2AP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NSD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GYPE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on